Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0001209191-21-058002

10% owner bought 200,000 shares at $11.00 ($2,200,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Frazier Life Sciences Public Fund, L.P. 10% owner 2021-09-23 Purchase +200,000 $11.00 $2,200,000 1,505,200 D
Open-market purchases · 200,000 sh · avg $11.00 · $2,200,000
Loading xslF345X03/doc4.xml…